Inovio Pharmaceuticals, Inc. Message Board

  • voisybay voisybay Jul 9, 2013 8:18 PM Flag

    Seeking Alpha Article May 2013

    I was fortunate enough to take a position in INO after reading the Seeking Alpha Article from May--my question is although INO has a revolutionary electropolation technology to allow the DNA vaccine to enter cells for a mulititude of applications--how close is INO to "turning a profit" and being able to market many of its vaccines. It appears most products are in the Phase I and II stage--which means it may still be several years before something gets approved through the FDA--I'm also impressed that the company has $0 debt so it appears as long as it forms partnerships and receives third party funding it can continue to operate---but still may not be profitable for many years---if this is the case will its potential be the "driving force" behind a consistent rise in its pps??

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INO
9.17-0.68(-6.90%)4:00 PMEDT